table of content
1 Active Transdermal Drug Delivery Device Market Overview
1.1 Product Overview and Scope of Active Transdermal Drug Delivery Device
1.2 Active Transdermal Drug Delivery Device Segment by Type
1.2.1 Global Active Transdermal Drug Delivery Device Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Patches
1.2.3 Gels
1.3 Active Transdermal Drug Delivery Device Segment by Application
1.3.1 Global Active Transdermal Drug Delivery Device Sales Comparison by Application: (2022-2028)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Use
1.4 Global Active Transdermal Drug Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Active Transdermal Drug Delivery Device Revenue 2017-2028
1.4.2 Global Active Transdermal Drug Delivery Device Sales 2017-2028
1.4.3 Active Transdermal Drug Delivery Device Market Size by Region: 2017 Versus 2021 Versus 2028
2 Active Transdermal Drug Delivery Device Market Competition by Manufacturers
2.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Manufacturers (2017-2022)
2.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Active Transdermal Drug Delivery Device Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Active Transdermal Drug Delivery Device Manufacturing Sites, Area Served, Product Type
2.5 Active Transdermal Drug Delivery Device Market Competitive Situation and Trends
2.5.1 Active Transdermal Drug Delivery Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Active Transdermal Drug Delivery Device Players Market Share by Revenue
2.5.3 Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Active Transdermal Drug Delivery Device Retrospective Market Scenario by Region
3.1 Global Active Transdermal Drug Delivery Device Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Active Transdermal Drug Delivery Device Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.3.1 North America Active Transdermal Drug Delivery Device Sales by Country
3.3.2 North America Active Transdermal Drug Delivery Device Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.4.1 Europe Active Transdermal Drug Delivery Device Sales by Country
3.4.2 Europe Active Transdermal Drug Delivery Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Active Transdermal Drug Delivery Device Market Facts & Figures by Region
3.5.1 Asia Pacific Active Transdermal Drug Delivery Device Sales by Region
3.5.2 Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.6.1 Latin America Active Transdermal Drug Delivery Device Sales by Country
3.6.2 Latin America Active Transdermal Drug Delivery Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country
3.7.2 Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Active Transdermal Drug Delivery Device Historic Market Analysis by Type
4.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
4.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2022)
4.3 Global Active Transdermal Drug Delivery Device Price by Type (2017-2022)
5 Global Active Transdermal Drug Delivery Device Historic Market Analysis by Application
5.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
5.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2022)
5.3 Global Active Transdermal Drug Delivery Device Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Novartis AG Active Transdermal Drug Delivery Device Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Noven Pharmaceuticals, Inc.
6.2.1 Noven Pharmaceuticals, Inc. Corporation Information
6.2.2 Noven Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.2.5 Noven Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Transdermal Corp.
6.3.1 Transdermal Corp. Corporation Information
6.3.2 Transdermal Corp. Description and Business Overview
6.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Product Portfolio
6.3.5 Transdermal Corp. Recent Developments/Updates
6.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
6.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
6.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
6.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Portfolio
6.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
6.5 Mylan N.V.
6.5.1 Mylan N.V. Corporation Information
6.5.2 Mylan N.V. Description and Business Overview
6.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Product Portfolio
6.5.5 Mylan N.V. Recent Developments/Updates
6.6 3M
6.6.1 3M Corporation Information
6.6.2 3M Description and Business Overview
6.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.6.4 3M Active Transdermal Drug Delivery Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Actavis, Inc.
6.6.1 Actavis, Inc. Corporation Information
6.6.2 Actavis, Inc. Description and Business Overview
6.6.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Actavis, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.7.5 Actavis, Inc. Recent Developments/Updates
6.8 Bayer AG
6.8.1 Bayer AG Corporation Information
6.8.2 Bayer AG Description and Business Overview
6.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bayer AG Active Transdermal Drug Delivery Device Product Portfolio
6.8.5 Bayer AG Recent Developments/Updates
6.9 Boehringer Ingelheim GmbH
6.9.1 Boehringer Ingelheim GmbH Corporation Information
6.9.2 Boehringer Ingelheim GmbH Description and Business Overview
6.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Portfolio
6.9.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.10 Corium International, Inc.
6.10.1 Corium International, Inc. Corporation Information
6.10.2 Corium International, Inc. Description and Business Overview
6.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.10.5 Corium International, Inc. Recent Developments/Updates
6.11 Echo Therapeutics, Inc.
6.11.1 Echo Therapeutics, Inc. Corporation Information
6.11.2 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Description and Business Overview
6.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.11.5 Echo Therapeutics, Inc. Recent Developments/Updates
6.12 GlaxoSmithKline plc
6.12.1 GlaxoSmithKline plc Corporation Information
6.12.2 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Description and Business Overview
6.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.12.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Portfolio
6.12.5 GlaxoSmithKline plc Recent Developments/Updates
7 Active Transdermal Drug Delivery Device Manufacturing Cost Analysis
7.1 Active Transdermal Drug Delivery Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
7.4 Active Transdermal Drug Delivery Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Active Transdermal Drug Delivery Device Distributors List
8.3 Active Transdermal Drug Delivery Device Customers
9 Active Transdermal Drug Delivery Device Market Dynamics
9.1 Active Transdermal Drug Delivery Device Industry Trends
9.2 Active Transdermal Drug Delivery Device Market Drivers
9.3 Active Transdermal Drug Delivery Device Market Challenges
9.4 Active Transdermal Drug Delivery Device Market Restraints
10 Global Market Forecast
10.1 Active Transdermal Drug Delivery Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Active Transdermal Drug Delivery Device by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Active Transdermal Drug Delivery Device by Type (2023-2028)
10.2 Active Transdermal Drug Delivery Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Active Transdermal Drug Delivery Device by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Active Transdermal Drug Delivery Device by Application (2023-2028)
10.3 Active Transdermal Drug Delivery Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Active Transdermal Drug Delivery Device by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Active Transdermal Drug Delivery Device by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
